185 related articles for article (PubMed ID: 28092607)
1. ProANP as a screening biomarker for hypertrophic cardiomyopathy in Maine coon cats.
Parzeniecka-Jaworska M; Garncarz M; Kluciński W
Pol J Vet Sci; 2016 Dec; 19(4):801-807. PubMed ID: 28092607
[TBL] [Abstract][Full Text] [Related]
2. Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy.
Hsu A; Kittleson MD; Paling A
J Vet Cardiol; 2009 May; 11 Suppl 1():S63-70. PubMed ID: 19395334
[TBL] [Abstract][Full Text] [Related]
3. Association of A31P and A74T polymorphisms in the myosin binding protein C3 gene and hypertrophic cardiomyopathy in Maine Coon and other breed cats.
Wess G; Schinner C; Weber K; Küchenhoff H; Hartmann K
J Vet Intern Med; 2010; 24(3):527-32. PubMed ID: 20412438
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of myocardial hypertrophy in a population of asymptomatic Swedish Maine coon cats.
Gundler S; Tidholm A; Häggström J
Acta Vet Scand; 2008 Jun; 50(1):22. PubMed ID: 18564408
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlation between the cardiac myosin binding protein C mutation A31P and hypertrophic cardiomyopathy in a cohort of Maine Coon cats: a longitudinal study.
Granström S; Godiksen MT; Christiansen M; Pipper CB; Martinussen T; Møgelvang R; Søgaard P; Willesen JL; Koch J
J Vet Cardiol; 2015 Dec; 17 Suppl 1():S268-81. PubMed ID: 26776585
[TBL] [Abstract][Full Text] [Related]
6. NT-proBNP measurement fails to reliably identify subclinical hypertrophic cardiomyopathy in Maine Coon cats.
Singh MK; Cocchiaro MF; Kittleson MD
J Feline Med Surg; 2010 Dec; 12(12):942-7. PubMed ID: 21036088
[TBL] [Abstract][Full Text] [Related]
7. Precision medicine validation: identifying the
Ontiveros ES; Ueda Y; Harris SP; Stern JA;
J Feline Med Surg; 2019 Dec; 21(12):1086-1093. PubMed ID: 30558461
[TBL] [Abstract][Full Text] [Related]
8. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
Jung SW; Kittleson MD
J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the myosin-binding protein C mutation in Maine Coon cats.
Fries R; Heaney AM; Meurs KM
J Vet Intern Med; 2008; 22(4):893-6. PubMed ID: 18498321
[TBL] [Abstract][Full Text] [Related]
10. N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy.
MacLean HN; Abbott JA; Ward DL; Huckle WR; Sisson DD; Pyle RL
J Vet Intern Med; 2006; 20(2):284-9. PubMed ID: 16594584
[TBL] [Abstract][Full Text] [Related]
11. The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure.
MacDonald KA; Kittleson MD; Larson RF; Kass P; Klose T; Wisner ER
J Vet Intern Med; 2006; 20(5):1093-105. PubMed ID: 17063701
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of the MYBPC3-A31P mutation in a large European feline population and association with hypertrophic cardiomyopathy in the Maine Coon breed.
Mary J; Chetboul V; Sampedrano CC; Abitbol M; Gouni V; Trehiou-Sechi E; Tissier R; Queney G; Pouchelon JL; Thomas A
J Vet Cardiol; 2010 Dec; 12(3):155-61. PubMed ID: 21051304
[TBL] [Abstract][Full Text] [Related]
13. Prospective echocardiographic and tissue Doppler imaging screening of a population of Maine Coon cats tested for the A31P mutation in the myosin-binding protein C gene: a specific analysis of the heterozygous status.
Carlos Sampedrano C; Chetboul V; Mary J; Tissier R; Abitbol M; Serres F; Gouni V; Thomas A; Pouchelon JL
J Vet Intern Med; 2009; 23(1):91-9. PubMed ID: 19175727
[TBL] [Abstract][Full Text] [Related]
14. Re: Association of A31P and A74T polymorphisms in the myosin binding protein C3 gene and hypertrophic cardiomyopathy in Maine Coon and other breed cats.
Kittleson MD; Meurs K; Munro M
J Vet Intern Med; 2010; 24(6):1242-3; author reply 1244. PubMed ID: 21054533
[No Abstract] [Full Text] [Related]
15. Effect of spironolactone on diastolic function and left ventricular mass in Maine Coon cats with familial hypertrophic cardiomyopathy.
MacDonald KA; Kittleson MD; Kass PH; White SD
J Vet Intern Med; 2008; 22(2):335-41. PubMed ID: 18346145
[TBL] [Abstract][Full Text] [Related]
16. Assessment of regional left ventricular systolic function by strain imaging echocardiography in phenotypically normal and abnormal Maine coon cats tested for the A31P mutation in the MYBPC3 gene.
Pellegrino A; Daniel AG; Pereira GG; Itikawa PH; Larsson MH
Can J Vet Res; 2017 Apr; 81(2):137-146. PubMed ID: 28408782
[TBL] [Abstract][Full Text] [Related]
17. Circulating concentrations of a marker of type I collagen metabolism are associated with hypertrophic cardiomyopathy mutation status in ragdoll cats.
Borgeat K; Dudhia J; Luis Fuentes V; Connolly DJ
J Small Anim Pract; 2015 Jun; 56(6):360-5. PubMed ID: 25622655
[TBL] [Abstract][Full Text] [Related]
18. Measurement of N-terminal proatrial natriuretic peptide in plasma of cats with and without cardiomyopathy.
Zimmering TM; Meneses F; Nolte IJ; Simon D
Am J Vet Res; 2009 Feb; 70(2):216-22. PubMed ID: 19231954
[TBL] [Abstract][Full Text] [Related]
19. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
Wess G; Daisenberger P; Mahling M; Hirschberger J; Hartmann K
Vet Clin Pathol; 2011 Jun; 40(2):237-44. PubMed ID: 21434959
[TBL] [Abstract][Full Text] [Related]
20. Body size and metabolic differences in Maine Coon cats with and without hypertrophic cardiomyopathy.
Freeman LM; Rush JE; Meurs KM; Bulmer BJ; Cunningham SM
J Feline Med Surg; 2013 Feb; 15(2):74-80. PubMed ID: 23001953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
